ECLS Versus IMPELLA™ as Bridge to LVAD (ECI-BLAD)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

92 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-01-20

Study Completion Date

2021-04-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this retrospective observational multicenter study the authors tested the hypothesis that the use of IMPELLA™ pump as bridge to bridge, by giving the opportunity of active rehabilitation, should improve patient's outcomes after the implantation of Left Ventricular Assist Device (LVAD).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Early Versus Differed Arterial Catheterization in Critically Ill Patients With Acute Circulatory Failure:

NCT03680963

Acute Circulatory Failure

COMPLETED NA

Ultrasound-guided Axillary Vein Access Versus Cephalic Venous Cutdown for Implantation of Cardiac Electronic Devices.

NCT04649788

Pacemaker Implantable Cardioverter-defibrillator

COMPLETED NA

Lower Limb Surveillance During VA-ECLS

NCT03910062

Cardiogenic Shock Cardiac Arrest Lower Limb Ischemia

COMPLETED

Efficacy Comparison of High and Very High Power Short Duration Pulmonary Vein Isolation

NCT05459831

Atrial Fibrillation

COMPLETED NA

AssocIation of PULSatility and Occurrence of Complications Related to Mechanically Assisted Circulatory Support

NCT04951999

End-stage Heart Failure

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

End stage heart failure patients admitted in Intensive Care Unit (ICU) for refractory cardiogenic shock requiring short-term mechanical circulatory support as a bridge to a long-term LVAD might benefit from early mobilization and rehabilitation with IMPELLA™ inserted via the axillary artery. The aim of this study is to compare the early rehabilitation and outcomes after LVAD implantation between patients previously treated by IMPELLA™ or ExtraCorporeal Life Support (ECLS)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiogenic Shock End-stage Heart Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

IMPELLA™ alone as bridge to LVAD

patients assisted by IMPELLA™ pump alone during the days preceding the implantation of long term LVAD (at least 48 hours for patients for whom an ECLS was previously used)

standard of care

Intervention Type OTHER

retrospective study: standard of care

ECLS alone or with IMPELLA™ as bridge to LVAD

patients assisted by ECLS (ExtraCorporeal life support) alone or simultaneously with IMPELLA™ until the implantation of LVAD

standard of care

Intervention Type OTHER

retrospective study: standard of care

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

standard of care

retrospective study: standard of care

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients supported with IMPELLA™ or ECLS for refractory cardiogenic shock as a bridge to long duration LVAD

Exclusion Criteria

* Patient refusing to give access to their medical chart
* Guardianship and curactorship
* Deprived of liberty
* short term mechanical circulatory system weaned before LVAD implantation

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No